Comment from Generic Animal Drug Alliance (GADA)

Summary: The Generic Animal Drug Alliance (GADA) argues that the draft guidance is too rigid because it does not allow for simplified response formats for minor Form 483 findings. They suggest that the guidance should provide flexibility to accommodate different levels of investigation and documentation based on the severity of the finding.